These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 32959645)
1. A Sequentially Responsive Nanosystem Breaches Cascaded Bio-barriers and Suppresses P-Glycoprotein Function for Reversing Cancer Drug Resistance. Liu J; Zhao L; Shi L; Yuan Y; Fu D; Ye Z; Li Q; Deng Y; Liu X; Lv Q; Cheng Y; Xu Y; Jiang X; Wang G; Wang L; Wang Z ACS Appl Mater Interfaces; 2020 Dec; 12(49):54343-54355. PubMed ID: 32959645 [TBL] [Abstract][Full Text] [Related]
2. Enhanced Efficacy against Drug-Resistant Tumors Enabled by Redox-Responsive Mesoporous-Silica-Nanoparticle-Supported Lipid Bilayers as Targeted Delivery Vehicles. Yang S; Zhang B; Zhao X; Zhang M; Zhang M; Cui L; Zhang L Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791591 [TBL] [Abstract][Full Text] [Related]
3. Reversal of Chemoresistance via Staged Liberation of Chemodrug and siRNA in Hierarchical Response to ROS Gradient. Dang J; Li Y; Yan J; Wu J; Cai K; Yin L; Zhou Z Adv Healthc Mater; 2024 Jun; 13(15):e2304130. PubMed ID: 38427696 [TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma. Zhang L; Lu J; Qiu L Int J Nanomedicine; 2016; 11():5205-5220. PubMed ID: 27785023 [TBL] [Abstract][Full Text] [Related]
5. Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer. Mao J; Qiu L; Ge L; Zhou J; Ji Q; Yang Y; Long M; Wang D; Teng L; Chen J Biomed Pharmacother; 2021 Feb; 134():111108. PubMed ID: 33341670 [TBL] [Abstract][Full Text] [Related]
6. Sequentially pH-Responsive Drug-Delivery Nanosystem for Tumor Immunogenic Cell Death and Cooperating with Immune Checkpoint Blockade for Efficient Cancer Chemoimmunotherapy. Jiang M; Chen W; Yu W; Xu Z; Liu X; Jia Q; Guan X; Zhang W ACS Appl Mater Interfaces; 2021 Sep; 13(37):43963-43974. PubMed ID: 34506118 [TBL] [Abstract][Full Text] [Related]
7. A Y Wang Y; Jiang Z; Yuan B; Tian Y; Xiang L; Li Y; Yang Y; Li J; Wu A Biomater Sci; 2019 Nov; 7(11):4748-4757. PubMed ID: 31508613 [TBL] [Abstract][Full Text] [Related]
8. A multifunctional nano-delivery system enhances the chemo- Zhao R; Ning X; Wang M; Yu A; Wang Y J Mater Chem B; 2021 Nov; 9(44):9174-9182. PubMed ID: 34698329 [TBL] [Abstract][Full Text] [Related]
9. Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy. Fang J; Zhang S; Xue X; Zhu X; Song S; Wang B; Jiang L; Qin M; Liang H; Gao L Int J Nanomedicine; 2018; 13():5113-5126. PubMed ID: 30233175 [TBL] [Abstract][Full Text] [Related]
10. Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy. Zhang CG; Zhu WJ; Liu Y; Yuan ZQ; Yang SD; Chen WL; Li JZ; Zhou XF; Liu C; Zhang XN Sci Rep; 2016 Mar; 6():23859. PubMed ID: 27030638 [TBL] [Abstract][Full Text] [Related]
11. Co-delivery of Paclitaxel/Atovaquone/Quercetin to regulate energy metabolism to reverse multidrug resistance in ovarian cancer by PLGA-PEG nanoparticles. Lu Q; Gao W; Chen Z; Liu Z; Wang J; Zeng L; Hu X; Zheng E; Zhang Q; Song H Int J Pharm; 2024 Apr; 655():124028. PubMed ID: 38518871 [TBL] [Abstract][Full Text] [Related]
12. pH/H Wang Y; Wang J; Gou K; Kang W; Guo X; Zhu K; Li S; Li H ACS Appl Mater Interfaces; 2021 Aug; 13(30):35397-35409. PubMed ID: 34313104 [TBL] [Abstract][Full Text] [Related]
13. Controlled synthesis and size effects of multifunctional mesoporous silica nanosystem for precise cancer therapy. Ma B; He L; You Y; Mo J; Chen T Drug Deliv; 2018 Nov; 25(1):293-306. PubMed ID: 29334793 [TBL] [Abstract][Full Text] [Related]
14. A Novel pH-Responsive Iron Oxide Core-Shell Magnetic Mesoporous Silica Nanoparticle (M-MSN) System Encapsulating Doxorubicin (DOX) and Glucose Oxidase (Gox) for Pancreatic Cancer Treatment. Qi G; Shi G; Wang S; Hu H; Zhang Z; Yin Q; Li Z; Hao L Int J Nanomedicine; 2023; 18():7133-7147. PubMed ID: 38054080 [TBL] [Abstract][Full Text] [Related]
15. Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood-Brain Barrier. Chen ZA; Wu CH; Wu SH; Huang CY; Mou CY; Wei KC; Yen Y; Chien IT; Runa S; Chen YP; Chen P ACS Nano; 2024 May; 18(20):12716-12736. PubMed ID: 38718220 [TBL] [Abstract][Full Text] [Related]
16. Dasatinib self-assembled nanoparticles decorated with hyaluronic acid for targeted treatment of tumors to overcome multidrug resistance. Zhang Y; Zeng X; Wang H; Fan R; Hu Y; Hu X; Li J Drug Deliv; 2021 Dec; 28(1):670-679. PubMed ID: 33792436 [TBL] [Abstract][Full Text] [Related]
17. Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer. Chen Y; Bathula SR; Li J; Huang L J Biol Chem; 2010 Jul; 285(29):22639-50. PubMed ID: 20460382 [TBL] [Abstract][Full Text] [Related]
18. A novel targeted co-delivery nanosystem for enhanced ovarian cancer treatment via multidrug resistance reversion and mTOR-mediated signaling pathway. Wang X; Xiong T; Cui M; Li N; Li Q; Zhu L; Duan S; Wang Y; Guo Y J Nanobiotechnology; 2021 Dec; 19(1):444. PubMed ID: 34949180 [TBL] [Abstract][Full Text] [Related]
19. Tumor acidity activated triphenylphosphonium-based mitochondrial targeting nanocarriers for overcoming drug resistance of cancer therapy. Yu H; Li JM; Deng K; Zhou W; Wang CX; Wang Q; Li KH; Zhao HY; Huang SW Theranostics; 2019; 9(23):7033-7050. PubMed ID: 31660085 [TBL] [Abstract][Full Text] [Related]
20. Protein-Gated Upconversion Nanoparticle-Embedded Mesoporous Silica Nanovehicles via Diselenide Linkages for Drug Release Tracking in Real Time and Tumor Chemotherapy. Yan H; Dong J; Huang X; Du X ACS Appl Mater Interfaces; 2021 Jun; 13(24):29070-29082. PubMed ID: 34101411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]